Showing results (911-920 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|September 7, 2018
Comprehensive analysis of body composition and insulin traits associated with intra-pancreatic fat deposition in healthy individuals and people with new-onset prediabetes/diabetes after acute pancreatitisRuma G Singh, Ngoc N Nguyen, Steve V DeSouza, et al.
Diabetes, Obesity & Metabolism|October 9, 2018
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerationsPeter G M Mol, Aliza Thompson, Hiddo J L Heerspink, et al.
Diabetes, Obesity & Metabolism|October 9, 2018
New clinical trial designs for establishing drug efficacy and safety in a precision medicine eraHiddo J L Heerspink, James List, Vlado Perkovic
Diabetes, Obesity & Metabolism|October 5, 2018
Effectiveness of high-intensity interval training combined with resistance training versus continuous moderate-intensity training combined with resistance training in patients with type 2 diabetes: A one-year randomized controlled trialJoão P Magalhães, Pedro B Júdice, Rogério Ribeiro, et al.
Diabetes, Obesity & Metabolism|June 27, 2018
Plasma levels of free fatty acids correlate with type 2 diabetes mellitusSandro Spiller, Matthias Blüher, Ralf Hoffmann
Diabetes, Obesity & Metabolism|June 12, 2019
Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogsJustin M Gregory, Guillaume Kraft, Melanie F Scott, et al.
Diabetes, Obesity & Metabolism|June 12, 2019
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial)Marie L Johansen, Morten Schou, Patrick Rossignol, et al.
Diabetes, Obesity & Metabolism|June 12, 2019
Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA ProtocolRonald M Goldenberg, Jeremy D Gilbert, Irene M Hramiak, et al.
Diabetes, Obesity & Metabolism|June 8, 2019
Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trialSylvia Franc, Michael Joubert, Ahmed Daoudi, et al.
Diabetes, Obesity & Metabolism|June 8, 2019
Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double-blind, phase 3 trialKohei Kaku, Hiroyuki Isaka, Taishi Sakatani, et al.
Pageof 632